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Abstract 
Background: Thermotherapy has been known to be one of the most effective adjuvants to radiotherapy (RT) in can‑
cer treatment, but it is not widely implemented clinically due to some limitations, such as, inadequate temperature 
concentrations to the tumor tissue, nonspecific and non‑uniform distribution of heat. So we constructed arginine‑
glycine‑aspartate peptides‑conjugated gold nanorods (RGD‑GNRs) that target the alpha(v) beta(3) Integrin (αvβ3) 
and investigate whether the photo‑thermal effect of RGD‑GNRs by near infrared radiation (NIR) could enhance the 
efficiency of RT in melanoma cancer cells.
Results: RGD‑GNRs could be seen both on the surface of the cell membranes and cytoplasm of A375 cells with high 
expression of αvβ3. After exposed to 808 nm NIR, RGD‑GNRs with various concentrations could be rapidly heated 
up. Compared to other treatments, flow cytometric analysis indicated that RT + NIR + RGD‑GNRs increased apop‑
tosis (p < 0.001) and decreased the proportion of cells in the more radioresistant S phase (p = 0.014). Treated with 
NIR + RGD‑GNRs, the radiosensitivity was also significantly enhanced (DMFSF2: 1.41).
Conclusion: Results of the current study showed the feasibility of using RGD‑GNRs for synergetic RT with photo‑
thermal therapy. And it would greatly benefit the therapeutic effects of refractory or recurrent malignant cancers.
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Background
Radiotherapy is an effective treatment for numerous 
cancers. It is estimated that radiotherapy contributes 
approximately 40  % towards curative treatment of can-
cer patients [1]. However, radiotherapy is mainly effective 
to G2/M phase tumor cells, with little effect to hypoxic 
cells and S phase cells, which is the major reasons for 
recurrence and deadly metastasis after radiotherapy. 
Thermotherapy, as a promising approach for killing radi-
oresistant cancer, has been known to be one of the most 
effective adjuvants to radiotherapy. In addition to direct 
toxic effect on tumor cells, hyperthermia can kill radi-
oresistant hypoxic cells and S phase cells [2]. Some pre-
clinical and clinical researchers showed synergetic effects 
of combining radiotherapy and thermotherapy, especially 
for refractory or recurrent malignant tumors [3–5]. How-
ever, the use of this combined therapy approach has not 
been adopted in routine clinical practice. This can prob-
ably be attributed to the limitations of thermotherapy, 
such as inadequate temperature concentrations to the 
deep tumor tissue, nonspecific and non-uniform distri-
bution of heat [6].
To overcome these obstacles, researchers have intro-
duced the use of nanotechnology to thermo-radiotherapy 
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[7]. Gold nanorods (GNRs) are ideally suited for photo-
thermal therapy because of their unique optical charac-
teristics [8, 9]. In particular, when light of wavelength in 
the visible to near infrared radiation (NIR) region inter-
acts with the particles much smaller than the incident 
wavelength, the electric field of the light wave induces 
coherent oscillation of the free electrons locally around 
the nanoparticle, with a frequency known as the local-
ized surface plasmon resonance frequency [10]. It is 
easy to tune the longitudinal surface Plasmon resonance 
(LSPR) wavelengths of GNRs through chemical meth-
ods, so that they can match with the center wavelengths 
of the laser [11]. GNRs of defined size can absorb NIR, 
leading to the temperature rise over 40  °C. Such tem-
perature is sufficient for sensitizing tumor cells to radi-
otherapy [12]. Furthermore, GNRs could be used as 
radiosensitizers due to the high atomic (Z) number ele-
ments (Au) [13]. Gold nanoparticles have been shown to 
cause sensitization with kilovoltage (KV) or Megavolt-
age (MV) X-ray in vitro and in vivo studies [14, 15]. We 
have previously shown that GNRs could sensitize mela-
noma cells to clinically relevant 6MV X-ray irradiation 
[15]. Moreover, by conjugating some specific antibodies 
and peptides, the amount of GNRs accumulated in the 
tumor site raises greatly, thus enhancing thermal and 
radio efficacy.
One of such molecular targets is integrins. Over-
expression of integrins has been reported in a wide 
variety of tumors, such as breast cancer, melanoma, 
and glioblastoma [16]. And it is approved that over-
expression of integrins is associated with tumor growth, 
metastasis and angiogenesis [17]. Among all the inte-
grins, alpha(v) beta(3) Integrin (αvβ3) is involved in 
tumor metastasis, angiogenesis, as well as radiosensitiv-
ity. Therefore, targeting αvβ3 has attracted a great deal of 
attention due to its role as a potential target for inhibition 
of angiogenesis and tumor growth. Arginine (R)-glycine 
(G)-aspartate (D) (RGD) is the most effective and widely 
used peptide sequence for stimulating cell adhesion on 
synthetic material surfaces. RGD molecular probes have 
been developed for selectively binding to αvβ3. Once the 
RGD sequence is recognized and bound to integrins, it 
initiates an integrin-mediated cell adhesion process and 
activates signal transduction between the cell and extra-
cellular matrix [18].
In this study, we synthesized multifunctional RGD 
(Arg-Gly-Asp peptides)-conjugated gold nanorods 
(RGD-GNRs). Such RGD-GNRs could produce signifi-
cant thermal effect upon 808 nm NIR and simultaneously 
serve as radiosensitizers by the high Z gold. RGD served 
as a targeting probe to specifically conjugate to tumor 
cells and we compared the effect of combined treatment 
of photo-thermal therapy and radiotherapy with either 




Before carrying out our studies, we synthesized and 
characterized the GNRs. The TEM image and measured 
UV–VIS spectrum are shown in Fig. 1. The length of the 
GNRs was about 44.4 nm and the width 15.6 nm (Fig. 1a, 
b). As shown in Fig.  1c, the LSPRs of GNRs located at 
805  nm. In our nanoconstruct, RGD peptide with high 
αvβ3 binding affinity and low cytotoxicity was conjugated 
to GNRs through a PEG linker (RGD-GNRs) [15].
RGD mediated specific cell uptake of RGD‑GNR
Next, we evaluated the selectivity of uptaking RGD-
GNRs in αvβ3 positive tumor cells. A375 melanoma 
cancer cells and MCF-7 breast cancer cells with differ-
ent expression of αvβ3 were chosen. Expression of αvβ3 
in these cell lines was investigated by flow cytometry. 
As shown in Fig.  2a, b, there was a significantly higher 
expression level of αvβ3 in A375 cells but lower expres-
sion level of that in MCF-7 cells. Meantime, significantly 
more RGD-GNRs were internalized in A375 cells than in 
MCF-7 cells (Fig. 2c, d). These results indicated that cell 
uptake of RGD-GNRs were mediated by αvβ3.
Photo‑thermal effect caused by GNRs under NIR irradiation
As is known to all, GNRs exhibit surface plasmon reso-
nance, allowing them to absorb far stronger light in 
near-infrared area (650–900  nm) [8, 9]. Since it is easy 
to tune the LSPR wavelengths of GNRs, they can match 
the center wavelength of NIR laser source in photo-
thermal treatment. In this study, the LSPR wavelength 
of GNR locates at 805 nm. In order to verify the poten-
tial of GNRs as the photo-thermal agent, GNRs and 
RGD-GNRs at different concentrations were exposed to 
808 nm NIR at a power density of 1 W/cm2 for 15 min. 
Figure  3 showed the heating curve of GNRs and RGD-
GNRs at different concentrations. It was shown that 
after exposure to the NIR, each concentration of GNRs 
or RGD-GNRs rapidly warmed within 1  min. An obvi-
ous concentration-dependent temperature increase was 
observed either in GNRs or in RGD-GNRs, After 15 min 
of continuous NIR irradiation at 1 W/cm2, the tempera-
ture of GNRs or RGD-GNRs group increased about 13 °C 
when the concentration was 0.05 mg/ml and the growth 
of temperature was of a concentration-dependent man-
ner. As expected, there was no temperature change at 
all in the groups that did not treated with RGD-GNRs 
followed by NIR irradiation. The above results well 
demonstrate the suitability of RGD-GNRs as efficient 
radiosensitizers and photo-thermal agents.
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Photo‑thermal effect enhanced radiosensitivity  
in A375 cells
Phase II/III clinical trials have demonstrated that hyper-
thermia combined with radiotherapy is beneficial for 
tumor control and survival in patients with radioresist-
ant tumors of different types [4]. Based on the clinical 
experience, we further assessed the synergistic effect 
between radiotherapy and photo-thermal therapy. Sur-
vival fraction at 2  Gy (SF2) and dose-modifying factor 
(DMF) values were used to quantify the radiosensitiz-
ing effect of the cells. DMFSF2: SF2 (radiation alone)/SF2 
(radiation +  treatment). We treated the A375 cells with 
RGD-GNRs by 808 nm NIR irradiation for 15 min com-
bined with RT. It was found that treatment of A375 cells 
with RGD-GNRs resulted in increased radiosensitiv-
ity with DMFSF2 =  1.288; however, treatment with NIR 
was not effective (DMFSF2 = 1.022). The radiosensitizing 
effect was further enhanced by combination treatment 
with RGD-GNRs and NIR, with a DMFSF2 of 1.413. These 
results confirmed that RGD-GNRs combined with NIR 
enhanced the radiosensitizing effect by photo-thermal 
effect.
Enhanced radiation‑induced apoptosis by photo‑thermal 
treatment
To identify the effect of photo-thermal treatment com-
bined with radiotherapy on apoptosis, we evaluated the 
apoptosis level based on the flow cytometry. As shown 
in Fig. 4, NIR or RGD-GNRs alone did not significantly 
increase the amount of cell apoptosis compared with the 
control group (NIR vs. Ctr, p  =  0.478; RGD-GNRs vs. 


















Fig. 1 a The TEM images of GNRs dispersed in PBS. Scale bar 50 nm. b The TEM images ofGNRs dispersed in PBS. Scale bar 20 nm. c Measured UV–
VIS absorbance spectrum of the synthesized GNRs, showing peak extinction at 805 and 532 nm, respectively.
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slightly enhanced apoptosis compared with control group 
(RT vs. Ctr, p =  0.007; RT and NIR vs. Ctr, p =  0.002). 
The combination of NIR and RGD-GNR with RT resulted 
in increased apoptosis compared with other treatment 
groups (p < 0.001). Taken together, these data confirmed 
the synergistic interaction between radiotherapy and 
photo-thermal treatment.
Decrease the proportion of cells in S phase 
by photo‑thermal treatment
Considering that hyperthermia-induced radiosensiti-
zation is known to be associated with more sensitive 
to S phase cells, which are resistant to radiation. It was 
determined whether a cell cycle rationale could be used 
to account for the greater efficacy of the photo-thermal 
treatment and radiotherapy combination (Fig.  5). As 
shown in Fig.  6, after treatment with RGD-GNRs and 
NIR for 24  h, there were a significant accumulation of 
cells in G2/M phase (p  =  0.022, compared with other 
treatment groups) and a drastic decrease of S phase cells 
(p = 0.014, compared with other treatment groups), No 
significant difference can be seen in G0/G1 phase cells 
among the three groups. So hyperthermia may sensitize 
cells to radiation by regulating the cell cycle. The com-
bination of thermotherapy and radiotherapy increases 
damage to all phases of tumor cells, but the killing effects 
of the S-phase cells are even more markedly enhanced. 
In addition to directly modulating the cell cycle, ther-
motherapy can also affect the radiosensitivity in another 
way. Hyperthermia leads to the denaturation of some 
proteins, including a variety of DNA-repair enzymes, 
resulting in irreversible damage [19].
Conclusion
In summary, we showed that RGD-GNRs significantly 
enhanced radiosensitivity in A375 cells with high expres-
sion of αvβ3. Moreover, RGD-GNRs showed greater radi-
osensitizating effect when combined with NIR irradiation 
then RGD-GNRs alone. The significantly enhanced radio-
sensitivity of RGD-GNRs could be attributed to: (1) RGD-
GNRs actively targeted to cancer cells because of high 
expression of αvβ3. (2) Potential effectiveness of GNRs 
as radiosensitizers for not only KV X-ray but also MV 
X-ray. (3) The energy of NIR could be absorbed by RGD-
GNRs and transferred into local thermal energy, making 
RGD-GNRs as an ideally candidates for photo-thermal 
treatment. (4) The synergistic interaction between radio-
therapy and thermotherapy. Currently, although extensive 
preclinical reports are available on the utility of gold nan-
oparticle for thermally therapeutic applications, there are 
few reports on using these features to improve the efficacy 
of radiotherapy. A potential limitation of this combined 
Fig. 2 Cellular uptake of RGD‑GNRs. a, b Representative photos of flow cytometry assay of the expression level of αvβ3 in A375 and MCF‑7 cells. c, 
d TEM analysis of A375 (c) and MCF‑7 cells (d) with and without internalized RGD‑GNRs.
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radio-photothermal treatment strategy is penetration 
depth of NIR irradiation. But, melanoma cancer, used in 
present study, is a superficial radioresistant malignant 
tumor, which is best suitable for the NIR induced photo-
thermal treatment. To our knowledge, this is the first 
report that describes use of the RGD conjugated GNRs 
induced hyperthermia as an adjuvant for radiotherapy to 
treat melanoma cancer. Our results provide an interest-
ing area for future radio-thermal therapy by some novel 
materials, such as nanoparticle, because it opens up new 
possibilities in cancer therapy.
Methods
Synthesis and characterization of RGD‑conjugated gold 
nanorods
The gold nanorods were synthesized using the seed-
mediated template-assisted protocol [20] by reducing 

















































Fig. 3 Heating curve of different concentrations of GNRs (a) and RGD‑GNRs (b) (0, 0.05, 0.1, 0.5, 1, 2 mg/ml) under 808 nm NIR at a power density of 
1 W/cm2.
























Fig. 4 Radiosensitizing effect by RGD‑GNRs and/or NIR. A375 cells 
were exposed with DMEM (control group), NIR, RGD‑GNRs (50 μg/
ml) or RGD‑GNRs + NIR for 1 h, then irradiated at 0–8 Gy with 6MV‑X 
ray. Cells were trypsinized, counted, and seeded at different dilutions. 
Colonies of 0.50 cells were counted approximately 2 weeks after 
treatment.
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The seed solution was produced by the reduction of 
chlorozuric acid (5  ml, 0.5  mmol) with ice-cold NaBH4 
(0.6  ml, 10  mmol) in the presence of CTAB (5  ml, 
0.2  mol) solution (Sinopharm Chemical Reagent Co., 
Ltd. Shanghai, China). For the growth solution, 100 ml of 
0.1 mol CTAB was first mixed with 0.01 mol AgNO3, fol-
lowed by 0.01 mol chloroauric acid, 0.1 mol AA, 0.5 mol 
H2SO4, and 250 μl of seed solution. Finally, the resulting 
solution was incubated at 30 °C over a period of 20 h. The 
procedure of preparing RGD conjugated GNRs is intro-
duced as follows. First, the as-prepared GNRs solution 
was centrifuged twice at 9,600  rpm for 25  min. Then, a 
stock solution of SH-PEG-COOH (10  mg/ml) (Shang-
hai Yare Biotech, Inc. Shanghai, China) was added into 
a freshly prepared GNR solution under vigorous stirring 
for 2  h. All the GNRs samples were centrifuged twice 
and redispersed in deionized water. The RGD peptides 
(China Peptides Co., Ltd. Shanghai, China) were cova-
lently attached to the outer ends of the PEG-GNRs via 
amide bonds, using the standard EDC-NHS reaction 
[21]. A solution of RGD in deionized water was added to 
a volume of PEGylated gold nanorods to react for 3 h and 
excess RGD peptides were removed by centrifugation at 
10,000 rpm for 10 min. The RGD-GNRs were dispersed 
in Dulbecco’s Modified Eagle Medium (Hyclone, Carls-
bad, CA, USA) and stored at 4  °C for later cell experi-
ments. GNRs samples were analyzed with a transmission 
electron microscopy (TEM) (JEM-2010HT, JEOL, Japan) 
operating at an accelerating voltage of 200  kV. UV–VIS 
absorbance spectra were measured with a UV–VIS spec-
trophotometer (Cary-100, Agilent, America) in the wave-
length range from 400 to 900 nm.
Cell lines and culture
Human melanoma A375 cells with high expression of 
αvβ3 and human breast cancer MCF-7 cells with low 
expression of αvβ3 were purchased from the Shanghai 
Institute of Cell Biology and Chinese Academy of Sci-
ences (Shanghai, China) and grown in 5 % CO2 incuba-
tor at 37  °C using Dulbecco’s Modified Eagle Medium 
(DMEM) with 10 % fetal bovine serum (Hyclone).
Integrin αvβ3 analysis
A375 and MCF-7 cells were collected and suspended in 
phosphate- buffered saline/0.2 % bovine serum albumin. 
A 200 μl sample of the suspension was incubated with a 
mouse antihuman integrin αvβ3 mAb LM609 (Millipore, 
Shanghai, China) or isotype-matched control antibody 
DD7 (Millipore) for 45 min at 4 °C. The cells were washed 
three times with phosphate-buffered saline and analyzed 
using a flow cytometry (Becton–Dickinson, Frank- lin 
Lakes, NJ, USA).
TEM analysis of cells with internalized gold nanorods
A375 and MCF-7 cells previously incubated with RGD-
GNRs were washed three times with phosphate-buffered 
saline and fixed with 2.5  % glutaraldehyde for 6  h. The 
cells were post-fixed in 1  % osmium tetroxide for 2  h, 
dehydrated in ethanol, and embedded in agar resin (Agar 
Scientific, Stansted, Essex, UK). Thin Sects.  (60–70 nm) 
were collected on copper grids, stained with methanol 
and lead citrate, and analyzed with a analyzed with a 
TEM (JEM-2010HT, JEOL, Japan) operating at an accel-
erating voltage of 200 kV.
Measurements of heating GNRs and RGD‑GNRs 
by near‑infrared radiation
The photo-thermal properties of gold nanorods were 
































Fig. 5 The apoptosis of the A375 cells after NIR or/and RGD‑GNRs 
treatment. A375 cells were treated with RGD‑GNRs or/and irradiation 
for 1 h prior to irradiation (6 mV X‑rays with a dose of 4 Gy). The cells 
were stained with Annexin V and propidium iodide, and apoptosis 






























Fig. 6 The changes in cell cycle distribution by treatment of RGD‑
GNRs and NIR in A375 cells. A375 cells were incubated with 0.05 mg/
ml RGD‑GNRs, then the cells were or were not irradiated with 808 nm 
NIR with the power density of 1 W/cm2 for 1 h. After 24 h, the cells 
were analyzed by flow cytometry.
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irradiation was accomplished using an Connet Highly 
Stabilized Laser Source System (VLSM-808-B-070), with 
a wavelength of 808 nm at a power density of 1 W/cm2 
and a spot size of 5  mm diameter. The GNRs or RGD-
GNRs were diluted in DMEM with various concentra-
tions. After ultrasonic dispersion, a 500  μl volume of 
gold nanorods with different concentrations were put 
into 600 μl EP tubes. Subsequently, these samples were 
irradiated with an NIR laser for 15 min. Meanwhile, the 
temperature was measured and the heating curves were 
drawn.
Clonogenic assay
Exponentially growing cells were exposed with DMEM 
(control group), NIR, RGD-GNRs (50  μg/ml) or RGD-
GNRs  +  NIR for 1  h, then irradiated at 0–8  Gy with 
6MV-X ray. After 48 h, the cells were detached, counted, 
and seeded at different dilutions according to the irradia-
tion dose and grown for 2  weeks to form colonies. The 
colonies were stained with 0.4 % crystal violet. Only colo-
nies containing ≥50 cells were scored. All experiments 
were repeated three times. Survival curves were fitted 
to a linear quadratic (LQ) model using Graphpad Prism 
software (version 5.0).
Cell cycle and apoptosis assays by flow cytometry
A375 cells (106 cells/ml) fixed in 95 % ethanol at −20 °C 
for 24  h were washed with cold phosphate-buffered 
saline, resuspended, and stained with propidium iodide 
(50 μg/ml phosphate-buffered saline; Invitrogen, Shang-
hai, China) for 15  min at 4  °C. Analysis was performed 
using a FACS Calibur flow cytometry. Cellular DNA con-
tent and cell cycle data were analyzed by flow cytometry 
using multicycle system 2.0 software. For the apoptosis 
assay, the cells were stained with Annexin-V-fluorescein 
isothiocyanate/propidium iodide (Invitrogen) and meas-
ured by flow cytometry. All tests were repeated three 
times.
Statistical analysis
All the experiments were completed in three triplicates, 
Statistical analysis was performed using Student’s t test, 
and p value was calculated based on two-tailed test. 
p < 0.05 was considered statistically significant. SPSS 11.0 
software was used for all statistical analyses.
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